180 related articles for article (PubMed ID: 24502396)
21. Costimulation of CD4+ and CD8+ T cells through CD26: the ADA-binding epitope is not essential for complete signaling.
De Meester IA; Kestens LL; Vanham GL; Vanhoof GC; Vingerhoets JH; Gigase PL; Scharpé SL
J Leukoc Biol; 1995 Sep; 58(3):325-30. PubMed ID: 7665988
[TBL] [Abstract][Full Text] [Related]
22. Caveolin-1, a binding protein of CD26, is essential for the anti-inflammatory effects of dipeptidyl peptidase-4 inhibitors on human and mouse macrophages.
Hiromura M; Nohtomi K; Mori Y; Kataoka H; Sugano M; Ohnuma K; Kuwata H; Hirano T
Biochem Biophys Res Commun; 2018 Jan; 495(1):223-229. PubMed ID: 29113797
[TBL] [Abstract][Full Text] [Related]
23. CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression.
Yamada Y; Jang JH; De Meester I; Baerts L; Vliegen G; Inci I; Yoshino I; Weder W; Jungraithmayr W
J Heart Lung Transplant; 2016 Apr; 35(4):508-17. PubMed ID: 26755203
[TBL] [Abstract][Full Text] [Related]
24. Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.
Arias-Pinilla GA; Dalgleish AG; Mudan S; Bagwan I; Walker AJ; Modjtahedi H
Sci Rep; 2020 Jan; 10(1):537. PubMed ID: 31953437
[TBL] [Abstract][Full Text] [Related]
25. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.
Bandoh N; Ogino T; Cho HS; Hur SY; Shen J; Wang X; Kato S; Miyokawa N; Harabuchi Y; Ferrone S
Tissue Antigens; 2005 Sep; 66(3):185-94. PubMed ID: 16101829
[TBL] [Abstract][Full Text] [Related]
27. CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders.
Thompson MA; Ohnuma K; Abe M; Morimoto C; Dang NH
Mini Rev Med Chem; 2007 Mar; 7(3):253-73. PubMed ID: 17346218
[TBL] [Abstract][Full Text] [Related]
28. A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition.
Hayashi M; Madokoro H; Yamada K; Nishida H; Morimoto C; Sakamoto M; Yamada T
Cancer Cell Int; 2016; 16():35. PubMed ID: 27134571
[TBL] [Abstract][Full Text] [Related]
29. Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies.
Torimoto Y; Dang NH; Tanaka T; Prado C; Schlossman SF; Morimoto C
Mol Immunol; 1992 Feb; 29(2):183-92. PubMed ID: 1371820
[TBL] [Abstract][Full Text] [Related]
30. Semiquantitative analysis of the effects of fixation and paraffin embedding on immunoreactivity of renal basement membranes to a monoclonal antibody against type IV collagen.
Yoshida T; Adachi E; Matsubara O; Kino J; Asamatsu C; Sato Y; Nakajima K; Fukushima S; Hayashi T
Arch Histol Cytol; 1992 Dec; 55(5):497-502. PubMed ID: 1295548
[TBL] [Abstract][Full Text] [Related]
31. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
[TBL] [Abstract][Full Text] [Related]
32. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
[TBL] [Abstract][Full Text] [Related]
33. CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma.
Nishida H; Hayashi M; Morimoto C; Sakamoto M; Yamada T
Blood Cancer J; 2018 Oct; 8(11):99. PubMed ID: 30348967
[TBL] [Abstract][Full Text] [Related]
34. Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.
Okamoto T; Yamazaki H; Hatano R; Yamada T; Kaneko Y; Xu CW; Dang NH; Ohnuma K; Morimoto C
Biochem Biophys Res Commun; 2018 Oct; 504(2):491-498. PubMed ID: 30197002
[TBL] [Abstract][Full Text] [Related]
35. Staining pattern of seven monoclonal anti-CD26 antibodies in leprosy: implications for the use of CD26 as a surrogate marker of a human Th1-like reaction.
Seitzer U; Scheel-Toellner D; Mattern T; Haas H; Flad HD; Gerdes J
Virchows Arch; 1998 Apr; 432(4):343-7. PubMed ID: 9565344
[TBL] [Abstract][Full Text] [Related]
36. Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma.
Yamamoto J; Ohnuma K; Hatano R; Okamoto T; Komiya E; Yamazaki H; Iwata S; Dang NH; Aoe K; Kishimoto T; Yamada T; Morimoto C
Br J Cancer; 2014 Apr; 110(9):2232-45. PubMed ID: 24743707
[TBL] [Abstract][Full Text] [Related]
37. Expression, purification, and characterization of human dipeptidyl peptidase IV/CD26 in Sf9 insect cells.
Dobers J; Zimmermann-Kordmann M; Leddermann M; Schewe T; Reutter W; Fan H
Protein Expr Purif; 2002 Aug; 25(3):527-32. PubMed ID: 12182835
[TBL] [Abstract][Full Text] [Related]
38. Reactivity of monoclonal antibody (mAb) GD9 with a cytoplasmic antigen preserved in formalin-fixed, paraffin-embedded gastrointestinal tumors.
D'Errico A; Facchini A; Meliconi R; Grigioni FW; Ferrone S
Hybridoma; 1991 Feb; 10(1):113-9. PubMed ID: 2032731
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue.
Birner P; Ritzi M; Musahl C; Knippers R; Gerdes J; Voigtländer T; Budka H; Hainfellner JA
Am J Pathol; 2001 Jun; 158(6):1991-6. PubMed ID: 11395376
[TBL] [Abstract][Full Text] [Related]
40. Establishment of anti-mesothelioma monoclonal antibodies.
Mizutani N; Abe M; Matsuoka S; Kajino K; Wakiya M; Ohtsuji N; Hatano R; Morimoto C; Hino O
BMC Res Notes; 2016 Jun; 9():324. PubMed ID: 27342200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
